TCON

TRACON Pharmaceuticals, Inc. Common Stock

Delisted

TCON was delisted on the 27th of June, 2024.

34 hedge funds and large institutions have $48.1M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.29M
2 +$3.29M
3 +$1.2M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.06M
5
Renaissance Technologies
Renaissance Technologies
New York
+$554K

Top Sellers

1 -$184K
2 -$178K
3 -$105K
4
Ameriprise
Ameriprise
Minnesota
-$86K
5
VF
Virtu Financial
New York
-$61.2K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$63K
27
$58K
28
$53K
29
$50K
30
$38K
31
$27K
32
$16K
33
$11K
34
$3K
35
36
37
38